1. Home
  2. AMCI vs FLNA Comparison

AMCI vs FLNA Comparison

Compare AMCI & FLNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo AMC Robotics Corporation Common Stock

AMCI

AMC Robotics Corporation Common Stock

N/A

Current Price

$0.82

Market Cap

26.3M

Sector

Finance

ML Signal

N/A

FLNA

Filana Therapeutics Inc. Common Stock

N/A

Current Price

$0.64

Market Cap

30.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AMCI
FLNA
Founded
2021
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Blank Checks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
26.3M
30.0M
IPO Year
2022
2000

Fundamental Metrics

Financial Performance
Metric
AMCI
FLNA
Price
$0.82
$0.64
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
★ $6.50
AVG Volume (30 Days)
130.9K
★ 462.6K
Earning Date
11-16-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
★ N/A
N/A
Revenue
$5,980,847.00
★ $41,119,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$0.78
$0.39
52 Week High
$15.75
$2.03

Technical Indicators

Market Signals
Indicator
AMCI
FLNA
Relative Strength Index (RSI) 27.43 48.13
Support Level N/A $0.43
Resistance Level $3.99 $0.68
Average True Range (ATR) 0.28 0.06
MACD -0.01 0.01
Stochastic Oscillator 1.16 73.00

Price Performance

Historical Comparison
AMCI
FLNA

About AMCI AMC Robotics Corporation Common Stock

AMC Robotics Corp is a technology solutions company that offers AI-powered smart security and robotics solutions. It currently sells smart hardware products designed for residential and commercial use, including smart cameras, driving recorders, action cameras, and Retina K cameras, which are marketed under the YI brand. AMC Robotics is also engaged in developing additional hardware products and technology capabilities, including IoT-enabled devices, AI-based features, wearable devices, and AI robotics. Using its technological capabilities, the company is developing robotic dogs, robotic arms, and robotic unloading systems, offering smart solutions for the logistics and warehousing sectors. It has two primary operating segments: North America, which generates maximum revenue, and Europe.

About FLNA Filana Therapeutics Inc. Common Stock

Filana Therapeutics Inc is a biotechnology company focused on developing novel, investigational therapies to modulate the filamin A protein for the treatment of central nervous system disorders, such as tuberous sclerosis complex (TSC)-related epilepsy, and other diseases associated with dysregulation or overexpression of filamin A. Its therapeutic product candidate, simufilam, is a proprietary small molecule oral treatment drug being studied for the treatment of TSC-related epilepsy.

Share on Social Networks: